198 related articles for article (PubMed ID: 27681377)
1. Investigation of Streptococcus salivarius-mediated inhibition of pneumococcal adherence to pharyngeal epithelial cells.
Manning J; Dunne EM; Wescombe PA; Hale JD; Mulholland EK; Tagg JR; Robins-Browne RM; Satzke C
BMC Microbiol; 2016 Sep; 16(1):225. PubMed ID: 27681377
[TBL] [Abstract][Full Text] [Related]
2. In vitro Inhibition of Clinical Isolates of Otitis Media Pathogens by the Probiotic Streptococcus salivarius BLIS K12.
Chen TY; Hale JDF; Tagg JR; Jain R; Voss AL; Mills N; Best EJ; Stevenson DS; Bird PA; Walls T
Probiotics Antimicrob Proteins; 2021 Jun; 13(3):734-738. PubMed ID: 33179212
[TBL] [Abstract][Full Text] [Related]
3. Antimicrobial effect of probiotic bacteriocins on
Reichardt E; Shyp V; Alig L; Verna C; Kulik EM; Bornstein MM
J Oral Microbiol; 2024; 16(1):2304971. PubMed ID: 38288293
[TBL] [Abstract][Full Text] [Related]
4. Effect of Streptococcus salivarius K12 on the in vitro growth of Candida albicans and its protective effect in an oral candidiasis model.
Ishijima SA; Hayama K; Burton JP; Reid G; Okada M; Matsushita Y; Abe S
Appl Environ Microbiol; 2012 Apr; 78(7):2190-9. PubMed ID: 22267663
[TBL] [Abstract][Full Text] [Related]
5. Lyophilized cell-free supernatants of the oral probiotics Streptococcus salivarius M18 and Streptococcus salivarius K12 show promises for milk safety.
Karaçam S; Tunçer S
Lett Appl Microbiol; 2023 Jan; 76(1):. PubMed ID: 36688767
[TBL] [Abstract][Full Text] [Related]
6. Influence of Oral Probiotic Streptococcus salivarius K12 on Ear and Oral Cavity Health in Humans: Systematic Review.
Zupancic K; Kriksic V; Kovacevic I; Kovacevic D
Probiotics Antimicrob Proteins; 2017 Jun; 9(2):102-110. PubMed ID: 28236205
[TBL] [Abstract][Full Text] [Related]
7. Oral Probiotics, Streptococcus salivarius K12 and M18, Suppress the Release of Volatile Sulfur Compounds and a Virulent Protease from Oral Bacteria: An In-Vitro Study.
Park JA; Lee GR; Lee JY; Jin BH
Oral Health Prev Dent; 2023 Aug; 21():259-270. PubMed ID: 37724895
[TBL] [Abstract][Full Text] [Related]
8. Interferon Gamma Response in Human Saliva Following Exposure to the Oral Probiotic Streptococcus salivarius BLIS K12.
Laws GA; Harold LK; Tagg JR; Hale JDF
Probiotics Antimicrob Proteins; 2024 Feb; 16(1):93-98. PubMed ID: 36477439
[TBL] [Abstract][Full Text] [Related]
9. Streptococcus salivarius inhibits immune activation by periodontal disease pathogens.
MacDonald KW; Chanyi RM; Macklaim JM; Cadieux PA; Reid G; Burton JP
BMC Oral Health; 2021 May; 21(1):245. PubMed ID: 33962608
[TBL] [Abstract][Full Text] [Related]
10. Extended Safety Data for the Oral Cavity Probiotic Streptococcus salivarius K12.
Burton JP; Chilcott CN; Wescombe PA; Tagg JR
Probiotics Antimicrob Proteins; 2010 Oct; 2(3):135-44. PubMed ID: 26781236
[TBL] [Abstract][Full Text] [Related]
11. A preliminary study of the effect of probiotic Streptococcus salivarius K12 on oral malodour parameters.
Burton JP; Chilcott CN; Moore CJ; Speiser G; Tagg JR
J Appl Microbiol; 2006 Apr; 100(4):754-64. PubMed ID: 16553730
[TBL] [Abstract][Full Text] [Related]
12. Antagonistic effects of Streptococcus and Lactobacillus probiotics in pharyngeal biofilms.
Humphreys GJ; McBain AJ
Lett Appl Microbiol; 2019 Apr; 68(4):303-312. PubMed ID: 30776138
[TBL] [Abstract][Full Text] [Related]
13. Antimicrobial activity of Streptococcus salivarius K12 on bacteria involved in oral malodour.
Masdea L; Kulik EM; Hauser-Gerspach I; Ramseier AM; Filippi A; Waltimo T
Arch Oral Biol; 2012 Aug; 57(8):1041-7. PubMed ID: 22405584
[TBL] [Abstract][Full Text] [Related]
14. Inhibitory effect of Streptococcus salivarius K12 and M18 on halitosis in vitro.
Yoo HJ; Jwa SK; Kim DH; Ji YJ
Clin Exp Dent Res; 2020 Apr; 6(2):207-214. PubMed ID: 32250565
[TBL] [Abstract][Full Text] [Related]
15. Preliminary investigations of the colonisation of upper respiratory tract tissues of infants using a paediatric formulation of the oral probiotic Streptococcus salivarius K12.
Power DA; Burton JP; Chilcott CN; Dawes PJ; Tagg JR
Eur J Clin Microbiol Infect Dis; 2008 Dec; 27(12):1261-3. PubMed ID: 18560907
[TBL] [Abstract][Full Text] [Related]
16. The commensal Streptococcus salivarius K12 downregulates the innate immune responses of human epithelial cells and promotes host-microbe homeostasis.
Cosseau C; Devine DA; Dullaghan E; Gardy JL; Chikatamarla A; Gellatly S; Yu LL; Pistolic J; Falsafi R; Tagg J; Hancock RE
Infect Immun; 2008 Sep; 76(9):4163-75. PubMed ID: 18625732
[TBL] [Abstract][Full Text] [Related]
17. Megaplasmids encode differing combinations of lantibiotics in Streptococcus salivarius.
Wescombe PA; Burton JP; Cadieux PA; Klesse NA; Hyink O; Heng NC; Chilcott CN; Reid G; Tagg JR
Antonie Van Leeuwenhoek; 2006 Oct; 90(3):269-80. PubMed ID: 16871420
[TBL] [Abstract][Full Text] [Related]
18. Probiotic
Wang Y; Li J; Zhang H; Zheng X; Wang J; Jia X; Peng X; Xie Q; Zou J; Zheng L; Li J; Zhou X; Xu X
Front Immunol; 2021; 12():684824. PubMed ID: 34149727
[TBL] [Abstract][Full Text] [Related]
19. Investigating the effects of probiotics on pneumococcal colonization using an in vitro adherence assay.
Dunne EM; Toh ZQ; John M; Manning J; Satzke C; Licciardi P
J Vis Exp; 2014 Apr; (86):. PubMed ID: 24797941
[TBL] [Abstract][Full Text] [Related]
20. Preliminary pediatric clinical evaluation of the oral probiotic Streptococcus salivarius K12 in preventing recurrent pharyngitis and/or tonsillitis caused by Streptococcus pyogenes and recurrent acute otitis media.
Di Pierro F; Donato G; Fomia F; Adami T; Careddu D; Cassandro C; Albera R
Int J Gen Med; 2012; 5():991-7. PubMed ID: 23233809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
